Facilitating radio communications in a mobile device
    1.
    发明申请
    Facilitating radio communications in a mobile device 审中-公开
    促进移动设备中的无线电通信

    公开(公告)号:US20070005741A1

    公开(公告)日:2007-01-04

    申请号:US11172440

    申请日:2005-06-30

    IPC分类号: G06F15/173

    CPC分类号: H04L67/00

    摘要: A system and method for managing radio communication availability in a mobile device is provided. A mobile device includes a communication management component that interacts with radio and network layer components on the mobile device to keep communications available. The interaction can correspond to the transmittal of instructions to the radio and network layer components, which can include instructions to send communications via a communication network.

    摘要翻译: 提供了一种用于管理移动设备中的无线电通信可用性的系统和方法。 移动设备包括与移动设备上的无线电和网络层组件进行交互以保持通信可用的通信管理组件。 交互可以对应于向无线电和网络层组件发送的指令,其可以包括经由通信网络发送通信的指令。

    METHOD AND APPARATUS FOR PAIRING BETWEEN BLUETOOTH DEVICES
    2.
    发明申请
    METHOD AND APPARATUS FOR PAIRING BETWEEN BLUETOOTH DEVICES 审中-公开
    用于配对蓝牙设备的方法和装置

    公开(公告)号:US20120167176A1

    公开(公告)日:2012-06-28

    申请号:US13336267

    申请日:2011-12-23

    IPC分类号: H04L9/00

    摘要: A method and apparatus for pairing between Bluetooth devices, If a pairing between Bluetooth devices is requested, a six-digit passkey is generated in an authentication process based on secure simple pairing (SSP). If a Bluetooth device (BD) address of a correspondent device is pre-registered and there are characters designated to the BD address, the designated characters instead of the passkey are outputted.

    摘要翻译: 用于蓝牙设备之间配对的方法和设备如果请求蓝牙设备之间的配对,则在基于安全简单配对(SSP)的认证过程中生成六位密码。 如果通信设备的蓝牙设备(BD)地址被预注册,并且有指定给BD地址的字符,则输出指定字符而不是密码。

    Method of use of radicicol for treatment of immunopathological disorders
    3.
    发明授权
    Method of use of radicicol for treatment of immunopathological disorders 失效
    使用根霉素治疗免疫病理学障碍的方法

    公开(公告)号:US5731343A

    公开(公告)日:1998-03-24

    申请号:US394148

    申请日:1995-02-24

    IPC分类号: A61K31/365 A61K31/335

    CPC分类号: A61K31/365

    摘要: The present invention provides a method of treating an immunopathological disorder having an etiology associated with production of a proinflammatory agent, by administering a compound of the formula: ##STR1## where R1 and R2 are independently H or --COR3; R3 is H, 1-50C alkyl, 1-20C alkoxy, 2-30C alkenyl, 2-30C alkenyloxy, 2-10 alkynyl, 6-14C aryl or aryloxy, a 5-6 membered heterocycle (containing 1-3 N, O and/or S heteroatoms and optionally fused to an aryl group), 3-8C cycloalkyl (optionally fused to aryl) or 5-8C cycloalkenyl; and R4 is a halogen. Examples of such proinflammatory agents include interleukin-1 (IL-1), interleukin-6 (IL-6), interferon-.gamma. (IFN-.gamma.), tumor necrosis factor-.alpha. (TNF-.alpha.), granulocyte macrophage-colony stimulating factor (GM-CSF), the growth related gene KC, cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), macrophage chemotactic protein (MCP), inducible nitric oxide synthetase (iNOS), macrophage inflammatory protein (MIP), tissue factor (TF), phosphotyrosine phosphatase (PTPase), and endotoxin.

    摘要翻译: 本发明提供了一种治疗具有与促炎症药物生产相关的病因的免疫病理学障碍的方法,方法是通过给予下式化合物:r -OR3; R3是H,1-50C烷基,1-20C烷氧基,2-30C烯基,2-30C烯氧基,2-10炔基,6-14C芳基或芳氧基,5-6元杂环(含1-3个N,O 和/或S杂原子并任选地与芳基稠合),3-8C环烷基(任选地与芳基稠合)或5-8C环烯基; R4是卤素。 这些促炎剂的实例包括白细胞介素-1(IL-1),白细胞介素-6(IL-6),干扰素-γ(IFN-γ),肿瘤坏死因子-α(TNF-α),粒细胞巨噬细胞集落刺激因子 (GM-CSF),生长相关基因KC,环氧合酶-1(COX-1),环氧合酶-2(COX-2),巨噬细胞趋化蛋白(MCP),诱导型一氧化氮合成酶(iNOS),巨噬细胞炎症蛋白 ),组织因子(TF),磷酸酪氨酸磷酸酶(PTPase)和内毒素。